2022-Sustainable Industrial Processing Summit
SIPS2022 Volume 19 Intl. Symp on Technological Innovations in Medicine and Covid19 and Infectious Diseases

Editors:F. Kongoli, F. Murad, T. Yoshikawa, S. Waldman, J. Ribas, S. Hirano, D. Joseph, R. Guerrant, W. Petri, H. Inufusa, H. Yedoyan, S. Heysell.
Publisher:Flogen Star OUTREACH
Publication Year:2022
Pages:130 pages
ISBN:978-1-989820-70-4(CD)
ISSN:2291-1227 (Metals and Materials Processing in a Clean Environment Series)
CD-SIPS2022_Volume1
CD shopping page

    Novel Aminoglycoside Antibiotics That Evade Bacterial Resistance Mechanisms

    Dev Arya1;
    1CLEMSON UNIVERSITY, Clemson, United States;
    Type of Paper: Regular
    Id Paper: 182
    Topic: 65

    Abstract:

    Aminoglycosides inhibit bacterial growth by binding to the A-site decoding region of the bacterial 16s ribosomal RNA (rRNA) within the 30S ribosomal subunit. Previous work has shown that there is approximately a five-fold difference in the affinity of neomycin for the human A-site model and the E. coli model. The methodology for synthesizing, screening for both ribosomal binding/selectivity and bacterial growth inhibition, and rapid analysis of the data provides a systematic method for identification of bacterial ribosome specific antibacterials that can evade bacterial resistance pathways. We have developed rapid synthetic and screening methods that rapidly identify compounds that discriminate between the two model rRNA structures.
    Novel potent aminoglycosides that show high selectivity for the bacterial ribosome over mammalian ribosome were identified. Our approach, coupled with a rapid solid phase synthesis of peptidic aminosugars, has identified active aminoglycosides that show large differences in binding affinity for the E. coli A-site vs. the human A-site. Synergistic applications with clinical antibiotics have allowed us to develop novel antimicrobials that can inhibit the growth of multidrug resistant bacteria.

    Keywords:

    Medicine;

    References:

    1. Jiang, Li; Watkins, D; Jin, Y; Gong, C; King, Ada; Washington, A; Green, K; Garneau-Tsodikova, S; Oyelere, A; Arya, D. "Rapid Synthesis and Screening of a Peptidic-aminosugar (PA) library targeting rRNA". ACS Chemical Biology 2015, May 15,1278-89.
    2. Degtyareva NN, Gong C, Story S, Levinson NS, Oyelere AK, Green KD, Garneau-Tsodikova S, Arya DP. Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin Conjugates. ACS Infect Dis. 2017 Mar 10;3(3):206-215

    Cite this article as:

    Arya D. (2022). Novel Aminoglycoside Antibiotics That Evade Bacterial Resistance Mechanisms. In F. Kongoli, F. Murad, T. Yoshikawa, S. Waldman, J. Ribas, S. Hirano, D. Joseph, R. Guerrant, W. Petri, H. Inufusa, H. Yedoyan, S. Heysell. (Eds.), Sustainable Industrial Processing Summit SIPS2022 Volume 19 Intl. Symp on Technological Innovations in Medicine and Covid19 and Infectious Diseases (pp. 51-52). Montreal, Canada: FLOGEN Star Outreach